Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 71Rectal Neoplasms 38Pancreatic Neoplasms 32Colonic Neoplasms 31Neoplasms 29Stomach Neoplasms 22Neoplasm Metastasis 22Carcinoma, Non-Small-Cell Lung 18Esophageal Neoplasms 16Unspecified Adult Solid Tumor, Protocol Specific 15Head and Neck Neoplasms 13Adenocarcinoma 11Squamous Cell Carcinoma of Head and Neck 10Breast Neoplasms 10Ovarian Neoplasms 8Lung Neoplasms 8Lymphoma, Non-Hodgkin 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Renal Cell 6Solid Tumor 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Gallbladder Neoplasms 5Cholangiocarcinoma 5Adenocarcinoma Of Esophagus 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Peritoneal Neoplasms 4Melanoma 4Liver Neoplasms 4

Interventions

Cyclophosphamide 9Topotecan 5Temozolomide 5Melphalan 5Irinotecan 5Busulfan 5fludarabine 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4liposomal doxorubicin 3fludarabine phosphate 3cabozantinib 3Vincristine 3regorafenib 2pegfilgrastim 2Sirolimus 2Doxorubicin 2Bone Marrow Transplantation 2trioctyl phosphine oxide 1trifluridine tipiracil drug combination 1thymoglobulin 1talazoparib 1selinexor 1seclidemstat 1racotumomab 1poly ICLC 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1olaparib 1niraparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma, Ewing × Fluorouracil × Clear all
NCT03715933 2026-05-22

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Inhibrx Biosciences, Inc

Phase 1 Recruiting
411 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡